Skip to main content
Caplight Logo









PreciseDx

PreciseDx

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.precisedx.ai/

Last Round

Series B

Extension

Jun 18, 2025

Total Funding Raised

$53.2M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

PreciseDx is a healthcare technology company that specializes in artificial intelligence-driven pathology diagnostics aimed at enhancing patient outcomes in cancer and other diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Precision Medicine, Healthcare Analytics, Medical Imaging

Business Model

B2B2C

Customer Profile

Usage-Based SaaS

AI Layer

Application

Keywords

digital pathologyAI diagnosticscomputational pathologybreast cancer risk assessmentprecision medicineAI pathologycancer recurrence predictiontissue analysisbiomarker discoveryoncology AImedical imaging AIpathology workflowusage-based diagnosticneurodegenerative disease diagnosticsAI-native pathology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PreciseDx Comparables

Compare PreciseDx with similar companies based on industry and business-model similarity.

PreciseDx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
StratifAI GmbH
84%
ArteraAI
83%
Valar Labs
82%

PreciseDx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionJun 18, 2025
Series BAug 21, 2024
Series AJan 11, 2022

Key People

Founding team and executive leadership

Gerardo Fernandez

Chief Scientific Officer and Founder

Founding Team

Eric Converse

Chief Executive Officer, Founding Board Member - Former Interim Chair

Founding Team

Ed Sitar

Chief Financial Officer

Executive Team

PreciseDx Investors

Notable investors and investment history

PreciseDx investors
InvestorRounds
GenHenn CapitalSeries B Extension, Series B
Philips VenturesSeries B Extension
Eventide FundsSeries B Extension, Series B
IBM VenturesSeries A
Hobart HealthcareSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 170% MoM, reaching 2.2K.

  • Aug 21, 2024

    $21M round led by Eventide Funds.

PreciseDx Filings

Explore SEC and related filing metadata, where available.

PreciseDx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PreciseDx's valuation, stock price, and market status.

Is PreciseDx a public or private company?

PreciseDx is a private company.

What is the current stock price of PreciseDx?

PreciseDx is a private company with no public stock price. No recent secondary market data is available.

How much is PreciseDx worth (valuation)?

Valuation information for PreciseDx is not publicly available.

Can I buy PreciseDx stock?

PreciseDx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PreciseDx's last funding round?

PreciseDx's most recent funding round was VC Round on June 18, 2025.

Who are the main investors in PreciseDx?

Key investors in PreciseDx include Philips Ventures, Eventide Funds.

Will PreciseDx IPO soon?

No public IPO plans have been announced for PreciseDx.

How can I track PreciseDx secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PreciseDx's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range23
Year Founded2020
Last FundingJun 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?